British Columbia, Canada, June 6, 2023: Till Capital Corporation (TSXV: TIL) ("Till") announces that a cease trade order has been issued in respect of trading in Till's securities by the British ...
Amtagvi (lifileucel) is the first FDA-approved TIL therapy for advanced melanoma, potentially offering long-term remission without frequent treatments. The treatment process involves extensive ...
Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466). This is an ASCO Meeting Abstract from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results